Navigation Links
Boston Scientific Announces Pricing of $2 Billion of Senior Notes
Date:12/10/2009

arket conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.



CONTACT:    Larry Neumann
            508-650-8696 (office)
            Investor Relations
            Boston Scientific Corporation

            Paul Donovan
            508-650-8541 (office)
            508-667-5165 (mobile)
            Media Relations
            Boston Scientific Corporation


SOURCE Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
2. Boston Scientific to Participate in Piper Jaffray Health Care Conference
3. Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
4. Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2009
5. Boston Scientifics Urology/Gynecology Products Featured in Studies at Global Congress
6. Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
7. Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant
8. Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefxs New Immunization Management Solution
9. Boston Scientific Announces Results for Third Quarter Ended September 30, 2009
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Amgen (NASDAQ: ... License Application (BLA) to the U.S. Food and Drug ... of high cholesterol. Evolocumab is an investigational fully human ... (PCSK9), a protein that reduces the liver,s ability to ... the blood. 1 ­ ...
(Date:8/28/2014)... -- Rx Safes, Inc., the manufacturer of fingerprint recognition home ... new war on drugs to reduce prescription drug abuse, ... than 2,500 children a day experiment with prescription drugs ... accessed from unsecured medicine cabinets, closets and drawers.  While law ... Safes will address the new age drug dealer in ...
(Date:8/28/2014)... 28. August 2014 Sequent ... der Patientenrekrutierung für eine IDE-Pivot-Studie („IDE" ... Beurteilung der Sicherheit und Wirksamkeit des ... („WEB") bekanntgegeben. Adam Arthur, MD, Dozent an ... Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt der WEB-IT-Studie, ...
Breaking Medicine Technology:Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9Rx Safes, Inc. Announces New War On Drugs 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
... ROG; OTCQX: RHHBY) announced plans today to expand its coagulation ... outpatient clinics with the development of a full line of ... is expected to be introduced in the U.S. and Canada ... Roche Diagnostics is the global market leader in ...
... ORLANDO, Fla., Oct. 4, 2011 The benefits of a ... Now, new research has emerged relating to the role gender ... Gender Differences in a Naturalistic Observational Study of Sleep ... the annual Obesity Society meeting in Orlando, Florida this week. ...
Cached Medicine Technology:Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3
(Date:8/28/2014)... glue directly on the nerve stumps, but this method ... glue to easily invade the nerve ends. Ordinarily, nerve ... the nerve ends into the conduit because the nerve ... and co-workers from the General Hospital of Chinese PLA ... defined the best parameters for its use through in ...
(Date:8/28/2014)... can be treated with nasal septum cells. Researchers at ... that cells taken from the nasal septum are able ... and can thus repair articular cartilage defects. The nasal ... joint environment is associated with the expression of so-called ... has published the research results together with the ...
(Date:8/28/2014)... One in every 200 Ontarians has been diagnosed with ... living with the disease increasing by 64 per cent ... researchers at the Institute for Clinical Evaluative Sciences (ICES), ... Ottawa Hospital Research Institute. That puts Ontario in the ... The study, published this week in Inflammatory Bowel ...
(Date:8/28/2014)... rheumatoid arthritis patients in the study who were on ... not take them as prescribed in the first six ... from 60 hospitals around the UK involved in the ... for Genetics and Genomics at The University of Manchester, ... the drugs correctly, known as ,non-adherence, reduced their effectiveness ...
(Date:8/28/2014)... 28, 2014 BCC Research ( http://www.bccresearch.com ... SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the global market ... in 2013. Driven by the need for replacement of ... in emerging geographies, the market is expected to grow ... (CAGR) of 8.5% from 2013 through 2018. , While ...
Breaking Medicine News(10 mins):Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Ontario has one of the highest rates of IBD in the world 2Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3
... NEW YORK (Nov. 22 2009) -- Physician-scientists from Weill Cornell ... to be a powerful target for the treatment of non-Hodgkin,s ... blood cells. By exploiting this mechanism, researchers have been able ... animal models. Promising results have led to the design ...
... ... can be both fun and joyous. It can also be stressful and tiring ... foods -- factors that can, over time, increase your risk of cancer. That,s ... 10 Food Tips that can help ensure a happier, more healthful holiday season, ...
... , WASHINGTON, Nov. 21 DNC Chairman ... to begin full debate of health insurance reform legislation. ... Senate took another historic step on the road to enacting ... will now have an opportunity to debate the health reform ...
... , , Association Discusses Key ... Reform , ST. CHARLES, Ill., Nov. 21 ... Affordable Health Care for America Act (H.R. 3962), and the ... decisive steps to fix our nation,s broken health care system. ...
... , ... addictive game, SplitWords, is now available on the iPhone and iPod Touch. , ... Mountain View, CA (PRWEB) November 21, 2009 ... iPod Touch. Split Words is designed to help banish that ,tip of the tongue, syndrome ...
... , Pioneering Neurologist Closer to Understanding ... Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical ... Boston, on Thursday, November 19, presented his laboratory,s research ... the launch of the MINDlink Foundation. , Dr. Schmahmann ...
Cached Medicine News:Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: